Home  /  Resource Library  /  Limited, But Not Eliminated, Excess Long Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited Field Radiotherapy

Limited, But Not Eliminated, Excess Long Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited Field Radiotherapy

Study examined toxicity and morbidity of chemotherapy for treatment of Hodgkin lymphoma.